搜尋
BioLine RX Ltd
BLRX添加自選
2.820USD
+0.100+3.72%
收盤 07-31 16:00（美東）報價延遲15分鐘
13.74M總市值
虧損本益比TTM
關於 BioLine RX Ltd 公司
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
BioLine RX Ltd簡介
公司代碼BLRX
公司名稱BioLine RX Ltd
上市日期Jan 30, 2007
CEOSerlin (Philip Adam)
員工數量28
證券類型Depository Receipt
年結日Jan 30
公司地址Modi'in Technology Park
城市MODIIN
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Israel
郵編7177871
電話97286429100
網址https://www.biolinerx.com/
公司代碼BLRX
上市日期Jan 30, 2007
CEOSerlin (Philip Adam)
BioLine RX Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Aharon Schwartz, Ph.D.
Dr. Aharon Schwartz, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Raphael (Rafi) Hofstein, Ph.D.
Dr. Raphael (Rafi) Hofstein, Ph.D.
Director
Director
--
--
Ms. Nurit Benjamini
Ms. Nurit Benjamini
External Director
External Director
--
--
Dr. Avraham (Avi) Molcho
Dr. Avraham (Avi) Molcho
External Director
External Director
--
--
Dr. Michael J. Anghel
Dr. Michael J. Anghel
Director
Director
--
--
Mr. Philip Adam (Phil) Serlin
Mr. Philip Adam (Phil) Serlin
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Sandra Panem, Ph.D.
Dr. Sandra Panem, Ph.D.
Director
Director
--
--
Ms. Mali Zeevi
Ms. Mali Zeevi
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Hillit Mannor Shachar
Dr. Hillit Mannor Shachar
Vice President - Business Development
Vice President - Business Development
--
--
Dr. Ella Sorani
Dr. Ella Sorani
Vice President - Development
Vice President - Development
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Aharon Schwartz, Ph.D.
Dr. Aharon Schwartz, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Raphael (Rafi) Hofstein, Ph.D.
Dr. Raphael (Rafi) Hofstein, Ph.D.
Director
Director
--
--
Ms. Nurit Benjamini
Ms. Nurit Benjamini
External Director
External Director
--
--
Dr. Avraham (Avi) Molcho
Dr. Avraham (Avi) Molcho
External Director
External Director
--
--
Dr. Michael J. Anghel
Dr. Michael J. Anghel
Director
Director
--
--
Mr. Philip Adam (Phil) Serlin
Mr. Philip Adam (Phil) Serlin
Chief Executive Officer
Chief Executive Officer
--
--
常見問題
BioLine RX Ltd的前五大股東是誰？
BioLine RX Ltd的前五大股東如下：Dr. Aharon Schwartz, Ph.D.
有多少機構持有BioLine RX Ltd(BLRX)的股份？
截至2026Q1，共有60家機構持有BioLine RX Ltd的股份，合計持有的股份價值約為46.33K，占公司總股份的1.06% 。與2025Q4相比，機構持股有所增加，增幅為-104547.00。